1
TÍTULO: Data standards for atrial fibrillation/flutter and catheter ablation: the European Unified Registries for Heart Care Evaluation and Randomized Trials (EuroHeart)
AUTORES: Batra, Gorav; Aktaa, Suleman; Camm, A. John; Costa, Francisco; Di Biase, Luigi; Duncker, David; Fauchier, Laurent; Fragakis, Nikolaos; Frost, Lars; Hijazi, Ziad; Juhlin, Tord; Merino, Jose Luis; Mont, Lluis; Nielsen, Jens Cosedis; Oldgren, Jonas; Polewczyk, Anna; Potpara, Tatjana; Sacher, Frederic; Sommer, Philipp; Tilz, Roland; Maggioni, Aldo P.; Wallentin, Lars; Casadei, Barbara; Gale, Chris P.; ...Mais
PUBLICAÇÃO: 2022, FONTE: EUROPEAN HEART JOURNAL-QUALITY OF CARE AND CLINICAL OUTCOMES, VOLUME: 9, NÚMERO: 6
INDEXADO EM: Scopus WOS
2
TÍTULO: Oral anticoagulants in coronary heart disease (Section IV) Position paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
AUTORES: Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Jean Philippe Collet; Sigrun Halvorsen; Kurt Huber; Jorgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; Joao Morais; Lars Hvilsted Rasmussen; Fabrizio Ricci; Dirk Sibbing; Agneta Siegbahn; Robert F Storey; Jurrien ten Berg; Freek W A Verheugt; Jeffrey I Weitz; ...Mais
PUBLICAÇÃO: 2016, FONTE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 115, NÚMERO: 4
INDEXADO EM: Scopus WOS
3
TÍTULO: Oral anticoagulants in coronary heart disease (Section IV). Position paper of the ESC Working Group on Thrombosis – Task Force on Anticoagulants in Heart Disease
AUTORES: De Caterina, R; Husted, S; Wallentin, L; Andreotti, F; Arnesen, H; Bachmann, F; Baigent, C; J.-P Collet; Halvorsen, S; Huber, K; Jespersen, J; Kristensen, SD; Lip, GYH; Morais, J; Rasmussen, LH; Ricci, F; Sibbing, D; Siegbahn, A; Storey, RF; ten Berg, J; Verheugt, FWA; Weitz, JI; ...Mais
PUBLICAÇÃO: 2016, FONTE: Thromb Haemost - Thrombosis and Haemostasis, VOLUME: 115, NÚMERO: 4
INDEXADO EM: CrossRef
4
TÍTULO: Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis
AUTORES: Felicita Andreotti; Bianca Rocca; Steen Husted; Ramzi A Ajjan; Jurrien ten Berg; Marco Cattaneo; Jean Philippe Collet; Raffaele De Caterina; Keith A A Fox; Sigrun Halvorsen; Kurt Huber; Elaine M Hylek; Gregory Y H Lip; Gilles Montalescot; Joao Morais; Carlo Patrono; Freek W A Verheugt; Lars Wallentin; Thomas W Weiss; Robert F Storey;
PUBLICAÇÃO: 2015, FONTE: EUROPEAN HEART JOURNAL, VOLUME: 36, NÚMERO: 46
INDEXADO EM: Scopus WOS CrossRef
5
TÍTULO: Ticagrelor Effects on Myocardial Infarction and the Impact of Event Adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) Trial  Full Text
AUTORES: Kenneth W Mahaffey; Claes Held; Daniel M Wojdyla; Stefan K James; Hugo A Katus; Steen Husted; Philippe Gabriel Steg; Christopher P Cannon; Richard C Becker; Robert F Storey; Nardev S Khurmi; Jose C Nicolau; Cheuk Man Yu; Diego Ardissino; Andrzej Budaj; Joao Morais; Debra Montgomery; Anders Himmelmann; Robert A Harrington; Lars Wallentin;
PUBLICAÇÃO: 2014, FONTE: JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, VOLUME: 63, NÚMERO: 15
INDEXADO EM: Scopus WOS CrossRef
6
TÍTULO: The efficacy of ticagrelor is maintained in women with acute coronary syndromes participating in the prospective, randomized, PLATelet inhibition and patient Outcomes (PLATO) trial
AUTORES: Steen Husted; Stefan K James; Richard G Bach; Richard C Becker; Andrzej Budaj; Magda Heras; Anders Himmelmann; Jay Horrow; Hugo A Katus; Riita Lassila; Joao Morais; Jose C Nicolau; Ph. Gabriel Steg; Robert F Storey; Daniel Wojdyla; Lars Wallentin;
PUBLICAÇÃO: 2014, FONTE: EUROPEAN HEART JOURNAL, VOLUME: 35, NÚMERO: 23
INDEXADO EM: Scopus WOS CrossRef
7
TÍTULO: Reduction in First and Recurrent Cardiovascular Events With Ticagrelor Compared With Clopidogrel in the PLATO Study
AUTORES: Payal Kohli; Lars Wallentin; Eric Reyes; Jay Horrow; Steen Husted; Dominick J Angiolillo; Diego Ardissino; Gerald Maurer; Joao Morais; Jose C Nicolau; Ali Oto; Robert F Storey; Stefan K James; Christopher P Cannon;
PUBLICAÇÃO: 2013, FONTE: CIRCULATION, VOLUME: 127, NÚMERO: 6
INDEXADO EM: Scopus WOS CrossRef
8
TÍTULO: Effect of vorapaxar on myocardial infarction in the thrombin receptor antagonist for clinical event reduction in acute coronary syndrome (TRA.CER) trial
AUTORES: Sergio Leonardi; Pierluigi Tricoci; Harvey D White; Paul W Armstrong; Zhen Huang; Lars Wallentin; Philip E Aylward; David J Moliterno; Frans Van de Werf; Edmond Chen; Luis Providencia; Jan E Nordrehaug; Claes Held; John Strony; Tyrus L Rorick; Robert A Harrington; Kenneth W Mahaffey;
PUBLICAÇÃO: 2013, FONTE: EUROPEAN HEART JOURNAL, VOLUME: 34, NÚMERO: 23
INDEXADO EM: Scopus WOS CrossRef
9
TÍTULO: Parenteral anticoagulants in heart disease: Current status and perspectives (Section II) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
AUTORES: Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Kurt Huber; Jorgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; Joao Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Jeffrey I Weitz;
PUBLICAÇÃO: 2013, FONTE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 109, NÚMERO: 5
INDEXADO EM: Scopus WOS
10
TÍTULO: General mechanisms of coagulation and targets of anticoagulants (Section I) Position Paper of the ESC Working Group on Thrombosis - Task Force on Anticoagulants in Heart Disease
AUTORES: Raffaele De Caterina; Steen Husted; Lars Wallentin; Felicita Andreotti; Harald Arnesen; Fedor Bachmann; Colin Baigent; Kurt Huber; Jorgen Jespersen; Steen Dalby Kristensen; Gregory Y H Lip; Joao Morais; Lars Hvilsted Rasmussen; Agneta Siegbahn; Freek W A Verheugt; Jeffrey I Weitz;
PUBLICAÇÃO: 2013, FONTE: THROMBOSIS AND HAEMOSTASIS, VOLUME: 109, NÚMERO: 4
INDEXADO EM: Scopus WOS
Página 1 de 2. Total de resultados: 17.